Mendelian randomization in COVID-19: Applications for cardiovascular comorbidities and beyond
Main Authors: | Yaqun Teng, Jiuyang Xu, Yang Zhang, Zhenyu Liu, Shuyang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235239642030222X |
Similar Items
-
Relationship between rheumatoid arthritis and cardiovascular comorbidity, causation or co-occurrence: A Mendelian randomization study
by: Min Wang, et al.
Published: (2023-03-01) -
Mendelian Randomization Supports a Causal Effect of Depression on Cardiovascular Disease as the Main Source of Their Comorbidity
by: Eco J. C. de Geus
Published: (2021-01-01) -
COVID-19 and cardiovascular comorbidities: An update
by: Rogério Teixeira, et al.
Published: (2020-08-01) -
Multiple Sclerosis and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study
by: Fangkun Yang, et al.
Published: (2022-03-01) -
Osteoarthritis and cardiovascular disease: A Mendelian randomization study
by: Zhao Wang, et al.
Published: (2022-11-01)